Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals

Hepato-Gastroenterology

Volumn 50, Issue 49, 2003, Pages 217-221

  Idilman, Ramazan ^a,b   Colantoni, Alessandra ^a   De Maria, Nicola ^a   Ustun, Celalettin ^c,d   Sam, Ramin ^a   Ing, Todd S ^a   Akan, Hamdi ^c   Koc, Haluk ^c   Van Thiel, David H ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b ANKARA UNIVERSITY   (Turkey)

^c Bone Marrow Transplantation Unit   (Turkey)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Hepatitis B virus; Immunosuppressed patients; Vaccine

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS PATIENT; HUMAN; IMMUNE DEFICIENCY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SIDE EFFECT; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY FAILURE, CHRONIC; LIVER DISEASES; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY;

EID: 0037270171     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Czesehinski PA, Binding N, Witting U: Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. Vaccine 2000; 18:1074-1080.
2. Alter M, Mast E: The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994; 23:437-455.
3. Lee WM: Hepatitis B virus infection. New Engl J Med 1997; 337:1733-1745.
4. Wiedmann M, Liebert UG, Oesen U, et al: Decreased immunogenicity of recombinant hepatitis B vaccine in chonic hepatitis C. Hepatology 2000; 31:230-234.
5. De Maria N, Idilman R, Colantoni A, Harig J, Van Thiel DH: Antibody response to HBV vaccination in individuals with HCV infection. Hepatology 2000; 32:444-445.
6. Miller ER, Alter MJ, Tokars JI: Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999; 33:356-360.
7. Hadler SC, Margolis HS: Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. In: Remington JS, Swartz MN (Eds.). Current clinical topics in infectious diseases. Boston: Blackwell Scientific, 1992; pp. 282-308.
8. Alexander GJM, Fikes J, Hoffman S, et al: The optimization of helper T lymphocyte function in vaccine development. Immunologic Res 1998; 18:79-92.
9. Rahman F, Dahnen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF: Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 2000; 31:521-527.
10. Fitch FW, Lancki DW, Gajewski TF: T-cell mediated immune regulation: help suppression. In: Paul WE (Ed.). Fundamenthal immunology. New York: Raven, 1993; pp. 773-790.
11. Stachowski J, Pollok M, Barth C, Maciejewski J, Baldamus CA: Non-responsiveness to hepatitis B vaccination in hemodialysis patients. Nephrol Dial Transplant 1994; 9:144-152.
12. Altman A, Coggeshall KM, Mustelin T: Molecular events mediating T cell activation. Adv Immunol 1989; 48:227-253.
13. Lee SD, Chan CY, Yu MY, Lu RH, Chang FY, Lo KJ: Hepatitis B vaccination in patients with chronic hepatitis C. J Med Virol 1999; 59:463-468.
14. Ustun C, Idilman R, Gurman G, et al: Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe. J Hepatol 1999; 31:202-209.
15. Nagler A, Ilan Y, Adler R, et al: Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Bone Marrow Transpl 1995; 15:475-478.
16. Peces R, de la Torre M, Alcazar R, Urra JM: Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis 1997; 29:239-245.
17. Bruguera M, Rodicio JL, Alcazar JM, Oliver A, Del Rio G, Esteban Mur R: Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodilaysis patients. Vaccine 1990; 8:S47-S49.
18. Martin P, Friedman LS: Chronic viral hepatitis and the management of chronic renal failure. Kidney Intern 1995; 47:1231-1241.
19. Ayli D, Ensari C, Ayli M, Mandiroglu F, Mut S: Effect of oral levamisole supplementation to hepatitis B vaccination on the rate of immune response in chronic hemodialysis patients. Nephron 2000; 84:291-292.
20. Sherlock S: The immunology of liver disease. Am J Med 1970; 49:693-706.
21. Alexander GJM,. Noari-Aria KT, Eddleston ALWF, Williams R: Contrasting relations between suppressor cell function and suppressor cell number in chronic liver disease. Lancet 1983; 1:1291-1293.
22. Egea E, Iglesias A, Salazar M, et al: The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991; 173:531-538.
23. Spinozzi F, Bertotto A, Rondoni F, Gerli R, Scalise F, Grignani F: T-lymphocyte activation pathways in alcoholic liver disease. Immunology 1991; 73:140-146.
24. Kronfol Z, Nair M, Hill E, Kroll P, Brower K, Greden J: Immune function in alcoholism: a controlled study. Alcoholism: Clin Exp Res 1993; 17:279-283.
25. Paronetto F: Immunologic factors in alcoholic liver disease. Seminar Liver Dis 1981; 3:232-243.
26. Garibaldi RA, Forrest JN, Bryan JA, Hanson BFA, Dismukes WE: Hemodialysis associated hepatitis. JAMA 1973; 225:304-384.
27. Kapoor D, Aggarwal SR, Singh NP, Thakur V, Sarin SK: Granulocyte-macrophage colony stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepatitis 1999; 6:405-409.
28. Hess G, Kreiter F, Kosters W, Deusch K: The effect of granulocyte-macrophage colony stimulating factor (GM-CSF) on hepatitis B vaccination in hemodialysis patients. J Viral Hepatitis 1996; 3:149-153.
29. Pol S, Legendre C, Mattlinger B, Bethelot P, Kreis H: Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients. J Hepatol 1990; 11:385-387.
30. Sezer S, Ozdemir FN, Guz G, et al: Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transpl Proceed 2000; 32:607-608.
31. Navarro JF, Teruel JL, Mateos M, Ortuno J: Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients. Clin Nephrol 1994; 41:113-116.
32. Cheng CH, Huang CC, Leu ML, Chiang CYF, Wu MS, Lai PC: Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 1997; 15:1353-1357.
33. Lum MG: Immune recovery after bone marrow transplantation. Hematol Oncol Clin North America 1990; 14:659-675.
34. Strasser SI, McDonald GB: Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management. Blood 1999; 93:1127-1136.
35. Lau GK, Lok AS, Liang RH, et al: Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 1997; 25:1497-1501.
36. Lau GK, Liang R, Lee CK, Lim WL: Is vaccination of donor adequate for clearance of hepatitis B virus after bone marrow transplantation? Lancet 1997; 349:1626-1627.